Monomeric near-infrared fluorescent proteins engineered from bacterial phytochromes and methods for making same
Nucleic acid molecules encoding monomeric near-infrared fluorescent proteins, variants and derivatives thereof are provided, as well as proteins and peptides encoded by these nucleic acids. Also provided are proteins that are substantially similar to, or derivatives, homologues, or mutants of, the above-referenced specific proteins. Also provided are fragments of the nucleic acids and the peptides encoded thereby, specifically split fluorescent proteins. In addition, host-cells, stable cell lines and transgenic organisms comprising above-referenced nucleic acid molecules are provided. The invention also refers to methods of making and using monomeric fluorescent proteins derived from bacterial phytochromes. The subject protein and nucleic acid compositions find use in a variety of different applications and methods, particularly for labeling of biomolecules, cells or cell organelles, and for detecting protein-protein interactions. Finally, kits for use in such methods and applications are provided.
1. An isolated nucleic acid encoding a protein comprising consecutive amino acid residues having 92% or greater identity to an amino acid sequence miRFP703 having SEQ ID NO:3, wherein the protein is a near-infrared fluorescent protein.
2. An isolated nucleic acid according to claim 1 , wherein the protein comprises an amino acid sequence selected from the group consisting of miRFP670v1 having SEQ ID NO:1, miRFP670 having SEQ ID NO:2, miRFP703 having SEQ ID NO:3, and miRFP709 having SEQ ID NO:4.
3. An isolated nucleic acid according to claim 1 , wherein the protein comprises at least one amino acid residue selected from the group consisting of S16, H17, C20, S20, H22, H43, C106, S127, V155, L179, C184, D201, T201, L201, F201, A201, I202, V202, C202, Q208, V211, I253, C253, D260, A268, V282, R292, K300, R301, and R305, and wherein the amino acid positions correspond to amino acid residue number positions in SEQ ID NO:3.
4. An isolated nucleic acid according to claim 3 , wherein the protein comprises at least one amino acid residue selected from the group consisting of D201, T201, L201, F201, A201, I202, V202, C202, I253, C253, K300, R301, and R305, and wherein the amino acid positions correspond to amino acid residue number positions in SEQ ID NO:3.
5. An isolated nucleic acid according to claim 4 , wherein the protein is a truncated amino acid sequence, wherein from 1-19 amino acid residues have been removed from the N-terminus.
6. An isolated nucleic acid encoding a split fragment of the protein sequence in claim 1 comprising at least amino acid residues 16-120 and corresponding to a PAS domain, wherein the amino acid positions correspond to amino acid residue number positions in SEQ ID NO:3.
7. An isolated nucleic acid encoding a split fragment of the protein sequence in claim 1 comprising at least amino acid residues 130-310 and corresponding to a GAF domain, wherein the amino acid positions correspond to amino acid residue number positions in SEQ ID NO:3.
8. An isolated nucleic acid according to claim 6 , wherein the protein comprises an amino acid sequence selected from the group consisting of miRFP-PAS having SEQ ID NO:5, and miRFP-PAS1 having SEQ ID NO:6.
9. A vector comprising the nucleic acid according to claim 1 .
10. An expression cassette comprising: (a) a transcriptional initiation region functional in an expression host; (b) the nucleic acid according to claim 1 ; and (c) a transcriptional termination region functional in said expression host.
11. A host cell or progeny thereof, comprising the expression cassette according to claim 10 as part of an extrachromosomal element or integrated into the genome of a host cell as a result of introduction of the expression cassette into the host cell.
12. A transgenic cell, or progeny thereof, comprising the nucleic acid according to claim 1 .
13. A kit comprising the nucleic acid according claim 1 and written instructions for use.
14. An isolated nucleic acid according to claim 7 , wherein the protein comprises an amino acid sequence selected from the group consisting of miRFP-GAF670 having SEQ ID NO:7, miRFP-GAF703 having SEQ ID NO:8, or miRFP-GAF709 having SEQ ID NO:9.